4/24
04:30 pm
iobt
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Low
Report
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
4/15
08:39 am
iobt
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness [Yahoo! Finance]
Low
Report
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness [Yahoo! Finance]
4/15
08:30 am
iobt
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
Low
Report
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
4/9
12:00 pm
iobt
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
Low
Report
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103
4/5
08:52 am
iobt
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer [Yahoo! Finance]
Medium
Report
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer [Yahoo! Finance]
4/5
08:30 am
iobt
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
Medium
Report
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
3/7
02:19 pm
iobt
IO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical Trials [Yahoo! Finance]
Neutral
Report
IO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical Trials [Yahoo! Finance]
3/6
04:23 pm
iobt
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting [Yahoo! Finance]
Medium
Report
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting [Yahoo! Finance]
3/6
04:11 pm
iobt
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Medium
Report
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
3/6
08:40 am
iobt
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Low
Report
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
3/5
04:56 pm
iobt
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results [Yahoo! Finance]
Low
Report
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results [Yahoo! Finance]
3/5
04:40 pm
iobt
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
Low
Report
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
2/26
04:09 pm
iobt
IO Biotech to Present at 44th Annual Cowen Health Care Conference [Yahoo! Finance]
Low
Report
IO Biotech to Present at 44th Annual Cowen Health Care Conference [Yahoo! Finance]
2/26
04:05 pm
iobt
IO Biotech to Present at 44th Annual Cowen Health Care Conference
Low
Report
IO Biotech to Present at 44th Annual Cowen Health Care Conference